Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.